Qiming granule in treating type 2 diabetic kidney disease patients: study protocol for a randomized controlled trial
Journal Title: Traditional Medicine Research - Year 2021, Vol 6, Issue 1
Abstract
Background: Diabetic kidney disease (DKD) is a chronic renal microvascular complication associated with abnormal glucose metabolism. According to traditional Chinese medicine (TCM) theory, Qi and Yin deficiency with blood stasis (the name of TCM symptoms, its main clinical features are fatigue, dry mouth, red or pale tongue, weak pulse, etc.) is the primary TCM syndrome of DKD, and Qiming granule (QMG) is suitable for the treatment of Qi and Yin deficiency with blood stasis syndrome. In view of this, we designed a randomized controlled trial to assess whether QMG is efficacious and safe in treating DKD patients. Methods: This protocol is for a randomized, double-blind, placebo-controlled, parallel group, six-centre clinical trial. A total of 180 participants will be randomized into the QMG group or placebo group, with a 1:1 ratio. The study will last for 50 weeks, including a 2-week run-in period, 24 weeks of intervention, and 24 weeks of follow-up. The experimental intervention will be QMG, and the control intervention will be a placebo. The primary outcome will be the 24h urinary albumin excretion ratio and the change in the albumin-to-creatinine ratio. The secondary outcome will be evaluation of renal function, fundus changes, management of blood lipids, TCM symptom improvement and safety assessments. Adverse events will be recorded during the trial. Discussion: This study is a randomized controlled trial to test the effectiveness and safety of QMG for DKD patients. The findings of this study will help to provide evidence-based recommendations in treating DKD patients. Trial registration: Chinese Clinical Trial Registry, ChiCTR-TRC-12002953. Registered 23 December 2012.
Authors and Affiliations
Jian Huo,Jun-Guo Duan,Xue-Jing Lu,Fu-Wen Zhang,Wen-Yuan Jian, Jia-Qing Sui,Jia-Ling Ai,Li-Sha Liu
Keywords
Related Articles
- EP ID EP690506
- DOI 10.12032/TMR20200105149
- Views 149
- Downloads 0
A prospective, randomized controlled trial of sanguisorba oil in the treatment of tamoxifen-related vaginitis in breast cancer patients
This study provides further insights into the clinical efficacy of sanguisorba oil in the treatment of tamoxifen-related (TAM) vaginitis in breast cancer patients. Sanguisorba oil for external use was effective in the tr...
Qingfei oral liquid downregulates TRPV1 expression to reduce airway inflammation and mucus hypersecretion injury caused by respiratory syncytial virus infection and asthma in mice
Objective: Qingfei oral liquid (QF), an experimental Chinese medicine prescription developed from the ancient priscription of traditional Chinese medicines Ma Xin Shi Gan decoction and Tingli Dazao Xie Fei decoction, has...
From religious manual to herbal pharmacopoeia: a textual study of the formation and transformation of Shennong’s Classic of Materia Medica
The earliest Ben Cao Jing (Classics of Materia Medica; 25 C.E.–220 C.E.) appeared during the reign of the Han Dynasty (202 B.C.E.–220 C.E.); their origins are traceable to the religious group called Fang Xian Dao. In add...
Modulation by anti-oketsu formulations in Kampo medicine of human arterial stiffness
Objective: In traditional herbal medicine (Kampo medicine in Japan), “sho” is diagnosed by the traditional assessments of clinical conditions. Among a variety of the shos, there is an “oketsu” syndrome, which is a stagna...
Investigation of the processing technology and mechanism of Kansui radix by licorice based on response surface methodology and integrative pharmacology
Background: The herbs should be processed by different methods before use, and the efficacy and toxicity of Chinese herbal medicines may change, which may enhance efficacy and reduce toxicity after processing. Gansui (Ka...